139 related articles for article (PubMed ID: 2226260)
1. [Tumor-induced immunosuppression in breast cancer patients].
Kharkevich DD; Polevaia EB; Kadagidze ZG
Eksp Onkol; 1990; 12(5):53-6. PubMed ID: 2226260
[TBL] [Abstract][Full Text] [Related]
2. [Disorders of the immune system in benign lesions and cancer of the breast].
Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
[TBL] [Abstract][Full Text] [Related]
3. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
4. [B cells and serum immunoglobulins in patients with breast pathology].
Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM
Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973
[TBL] [Abstract][Full Text] [Related]
5. [Lymphocytes of the blood, regional lymph nodes and tumor tissue in breast cancer].
Bazhenov SM; Dorosevich AE; Naperstnikov VV
Vopr Onkol; 1988; 34(9):1040-8. PubMed ID: 3055674
[No Abstract] [Full Text] [Related]
6. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
7. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
9. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
10. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43.
Reinerová M; Veselovská Z; Ausch C; Rosen HR
Neoplasma; 1996; 43(6):363-6. PubMed ID: 8996559
[TBL] [Abstract][Full Text] [Related]
12. [An update on the clinical and pathogenetic value of a lymphocyte subpopulation study in systemic lupus erythematosus].
López-Gómez M; Sampalo Lainz A; Jiménez-Alonso J
An Med Interna; 1992 Apr; 9(4):200-4. PubMed ID: 1581459
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
14. Engraftment potential of adult spleen cells in vitro and in vivo.
Dor FJ; Cooper DK
Transpl Immunol; 2006 Aug; 16(2):131. PubMed ID: 16860717
[No Abstract] [Full Text] [Related]
15. Induction of immune tolerance: a role for Natural killer T lymphocytes?
Margalit M; Ilan Y
Liver Int; 2005 Jun; 25(3):501-4. PubMed ID: 15910485
[TBL] [Abstract][Full Text] [Related]
16. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
[TBL] [Abstract][Full Text] [Related]
17. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.
Wu F; Wang ZB; Lu P; Xu ZL; Chen WZ; Zhu H; Jin CB
Ultrasound Med Biol; 2004 Sep; 30(9):1217-22. PubMed ID: 15550325
[TBL] [Abstract][Full Text] [Related]
18. Invariant NKT cells and tolerance.
Nowak M; Stein-Streilein J
Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
[TBL] [Abstract][Full Text] [Related]
19. [The lymphocyte immunological phenotype of young and middle-aged breast cancer patients].
Chobanian NS; Letiagin VP; Savel'eva EV; Zabotina TN; Baryshnikov AIu; Kadagidze ZG
Vopr Onkol; 1992; 38(5):548-54. PubMed ID: 1300753
[TBL] [Abstract][Full Text] [Related]
20. [Cooperation of B- and T-lymphocytes of the human in vitro and in vivo].
Ambrosius H; Schäffner H
Z Gesamte Inn Med; 1980 Jan; 35(2):38-42. PubMed ID: 6447413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
